Skip to content
Home » ACCESS Co., Ltd. IP Infusion’s sales in 2023 will increase by 61% compared to the previous year, and profits will reach a record high

ACCESS Co., Ltd. IP Infusion’s sales in 2023 will increase by 61% compared to the previous year, and profits will reach a record high

ACCESS
IP Infusion’s FY2023 sales will increase 61% year-on-year, and profits will reach record high
– Strong momentum strengthens our position as an open network solutions provider that replaces traditional vendors –
……
IP Infusion (Headquarters: California, U.S.; CEO: Jun Ogata) announced today that its dollar-denominated sales for the full year 2023* have increased significantly by 61% year-on-year, and its profits have reached a record high. We are pleased to announce.
In 2023, 95 new customers will adopt IP Infusion’s robust solution, and 41 new partners will join IP Infusion’s extensive and curated open network ecosystem, bringing the number of partners to 127. did. In addition, we have received 351 repeat orders from existing OcNOS customers, making IP Infusion a leading disaggregation solution that replaces traditional vendors such as Cisco, Juniper Networks, and Arista Networks. We have solidified our role as a provider.
To date, more than 42,000 OcNOS licenses have been sold and 2 million ports have been shipped worldwide. IP Infusion’s products are recognized as carrier-grade products that deliver flexibility, reliability, and lower total cost of ownership (TCO), strengthening IP Infusion’s position in the market.
Atsushi Ogata, CEO of IP Infusion,
“We are very pleased to see strong demand for IP Infusion’s software and open, disaggregated network solutions that led to significant growth in our business throughout fiscal year 2023. Against the backdrop of today’s volatile global economy, A mature, cost-effective, end-to-end, open solution is needed to enable secure and reliable networks. We are confident that we can provide a solution.”
IP Infusion announced 15 new OcNOS customers acquired in 2023. These include companies such as Africell Sierra Leone, Amplex Internet, BroadStar, DojoNetworks, EXATEL, Haefele Connect, Kinetix Networks, MetaLINK Techologies, Multinet, Netplus Broadband, Pine Networks, Scott Data, Telcom, Targo, and Vyve Broadband. OcNOS’ use cases in aggregation routers, data centers, and cell site routers continue to drive overall sales as customers expand their networks and migrate to open networks.
Key industry events in 2023 include IP Infusion entering into a strategic partnership with NTT DATA, part of the Nippon Telegraph and Telephone Corporation (NTT) Group. NTT DATA and IP Infusion have announced a collaboration to develop the market using open network solutions. In addition, IP Infusion announced that it will provide technical support for the development of “Beluganos,” a new network operating system (NOS) for White Box that realizes NTT’s IOWN concept, and will support NTT and NTT Group. We provide sales and support to global markets in cooperation with NTT Advanced Technology
Corporation, our technological core company.
Industry honors for 2023 include IP Infusion being named a “Leader”, “Outperformer” and “Platform Player” for the third consecutive year in the three NOS categories of technology analyst group GigaOm’s annual “Radar Report” There are many things that have happened. IP Infusion’s OcNOS is the most comprehensive platform form of the more than 20 NOS evaluated by GigaOm analysts, and as a NOS vendor, IP Infusion It was rated as overwhelming.
IP Infusion continues to lead the global networking industry by providing innovative, flexible and cost-effective solutions for building open networks.
* IP Infusion’s full fiscal year 2023 is from January to December 2023. ■About IP Infusion
IP Infusion is a global provider of open network software and solutions for carriers, service providers and data center operators. IP Infusion’s solutions have been installed in over hundreds of companies and operated in thousands of cases, making us the market leader. IP Infusion’s solutions enable network operators to accelerate innovation, streamline operations, and reduce total cost of ownership (TCO) by disaggregating networks. It also enables network OEMs to decouple network devices to reduce time to market, offer comprehensive services, and achieve carrier-grade robustness. IP Infusion is headquartered in Santa Clara, California, USA, and is independently operated as a wholly owned subsidiary of ACCESS, Inc.
[Image: https://prtimes.jp/i/11476/438/resize/d11476-438-7fe3cea5dcc7952f8cc9-0.png&s3=11476-438-fc630cc90acce65198c35f04693cddfb-620×155.png ]
https://www.ipinfusion.com/
■About ACCESS Co., Ltd.
ACCESS (TSE Prime: 4813) has been an independent software company since its establishment in 1984, providing advanced mobile and network software technologies for the telecommunications, broadcasting, automotive, home appliances, publishing, and energy infrastructure industries around the world. We provide IT solutions. Utilizing our development capabilities and know-how in virtualization technology for mobile software that has been installed on over 1.5 billion devices and network software that has been installed in over 100 companies, we are currently developing a DX/DX system that combines embedded and cloud technology. We are focusing on the development and
commercialization of IoT solutions. We are also promoting
international expansion with subsidiaries in Asia, the United States, and Europe.
https://www.access-company.com/
*ACCESS and the ACCESS logo are registered trademarks or trademarks of ACCESS Co., Ltd. in Japan, the United States, and other countries. *IP Infusion, the IP Infusion logo, and OcNOS are trademarks or registered trademarks of IP Infusion Inc. in the United States and other countries.
*Beluganos is a registered trademark of NTT.
*Other company names and product names mentioned in this text are registered trademarks or trademarks of each company.
More details about this release:
https://prtimes.jp/main/html/rd/p/000000438.000011476.html



%d